CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.

Marta Milà-AlomàAnn BrinkmalmNicholas J AshtonHlin KvartsbergMahnaz ShekariGrégory OpertoGemma SalvadóCarles FalconJuan-Domingo GispertNatalia Vilor-TejedorEider M Arenaza-UrquijoOriol Grau-RiveraAleix Sala-VilaGonzalo Sanchez-BenavidesJosé María González-de-EchávarriCarolina MinguillonKarine FauriaAida Niñerola-BaizánAndrés PerissinottiGwendlyn KollmorgenIvonne SuridjanHenrik ZetterbergJosé Luis MolinuevoKaj BlennowMarc Suarez-Calvetnull null

Published in: Neurology (2021)

ClinicalTrials.gov Identifier NCT02485730.

Keyphrases

contrast enhanced
computed tomography
magnetic resonance imaging
mild cognitive impairment
pet ct
positron emission tomography
physical activity
diffusion weighted imaging
cell therapy
risk factors
prefrontal cortex
pet imaging
magnetic resonance